Saturday, July 12, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News
Home Latest

HSE Primary Care Reimbursement Scheme

Robyn Maginnis by Robyn Maginnis
4 November 2024
in Latest, News
0
HSE Primary Care Reimbursement Scheme

The HSE has published the PCRS 2023 Statistical Analysis of Claims and Payments Report. It provides an overview of over €4bn in reimbursements and payments made in 2023, representing a €260m increase over 2022.

These payments were made through primary care schemes, including the GMS, Drugs Payment, Dental Treatment, Long Term Illness, and Community Ophthalmic schemes, and in relation to High-Tech drugs.

According to Shaun Flanagan Assistant National Director PCRS, “The PCRS Annual Statistical Report provides us with the data and analysis of the real impact and difference the services provided by our partners in the community such as GPS and pharmacists are making for our patients.

“In addition, these schemes provide more drugs in the community and hospitals for our patients and service users, making life-enhancing improvements for them. The HSE is funding more high-tech drugs than ever before; there is also more funding for hospital cancer drugs and MS drugs. Our patients and services users can access more services than ever with increases in GP access and care.”

Key report findings include:

• 42% of the population now has access to free GP care, thanks to the expansion of the eligibility criteria in 2023.

• Universal GP visit card access was extended to all children under 8 years of age from 11th August 2023, with a change in the means assessment threshold to extend eligibility to those on or below the median income came into effect towards the end of 2023.

This report also highlights the number of pharmacy items dispensed and payments to suppliers and manufacturers of High-Tech drugs, including an additional ¤4.95m spend on high-tech patient care fees. It details hospital payments in relation to Oncology Drugs and Medicines with over €36m more funding available in 2023, the National Hepatitis C Treatment Programme and a further €8.2m provided for Multiple Sclerosis Services. There was also an increase in investments in GP developments, with an additional €300,000 provided compared to 2022.

PCRS supports the delivery of a wide range of services to the general public through approximately 6,550 primary care contractors (general practitioners, dentists, pharmacists and optometrists/ophthalmologists) across a range of community health schemes.

Read our latest News Here

Read IPN November Here

Tags: Irish PharmacyIrish Pharmacy News
Previous Post

Three Decades Strong: Théa Pharma’s Journey of Success and Growth

Next Post

Budget 2025: €30m for new medicines is significant for patients as it will allow for the continuous flow of new life-enhancing treatments

Next Post
Budget 2025: €30m for new medicines is significant for patients as it will allow for the continuous flow of new life-enhancing treatments

Budget 2025: €30m for new medicines is significant for patients as it will allow for the continuous flow of new life-enhancing treatments

Clonmel Healthcare delivers over 200 free health checks at the Clonmel Show

Clonmel Healthcare delivers over 200 free health checks at the Clonmel Show

11 July 2025
RCSI opens next-generation laboratories to power the future of pharmacy and biomolecular sciences 

RCSI opens next-generation laboratories to power the future of pharmacy and biomolecular sciences 

10 July 2025
Mater Private Network announces €5.6 million investment in innovative cancer care technology

Mater Private Network announces €5.6 million investment in innovative cancer care technology

3 July 2025

RECOMMENDED NEWS

Looking for a comprehensive eye health food supplement? Look no further than ACTASE™ Lutein ZA. Find out more here.

Looking for a comprehensive eye health food supplement? Look no further than ACTASE™ Lutein ZA. Find out more here.

3 years ago
Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

2 years ago
Best Marketing/Training Campaign 2021

Best Marketing/Training Campaign 2021

4 years ago
AYA Announces Brand Partnership with Ireland’s Rising International female football player Amber Barrett

AYA Announces Brand Partnership with Ireland’s Rising International female football player Amber Barrett

2 years ago
https://twitter.com/Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Follow us on social media:

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login